



Over the past 20 years, there has been a substantial increase in 
the numbers of people with diabetes. It is one of the most costly 
and burdensome chronic diseases of our time. The disease is 
one of the leading causes of blindness and the most common 
cause of end-stage renal disease in developed countries. It 
is also an important cause of cardiovascular complications. 
Treatment is complex and costly – direct health care costs range 
from 2.5% to 15% of health budgets. 
According to the latest World Health Organization report, 
the number of people worldwide with diabetes increased from 
30 million to 171 million between 1985 and 2000. A startling 
4.6% of adults aged over 20 are now estimated to suffer from 
the disease. Although prevalence rates are generally higher in 
developed countries than in the developing world, there is a 
steady increase in prevalence among those in the developing 
world. The main cause is the rise in type 2 diabetes that is 
associated with increasing levels of obesity and an ageing 
population. 
This is not expected to get better any time soon. WHO has 
predicted that the global prevalence of adults with diabetes will 
reach 6.4% by 2030 – and these estimates are based on the rather 
unlikely assumption that obesity rates will remain static.
The authors of this recent paper in the Lancet used a validated 
diabetes registry taken from hospital records and physician 
claims to describe trends in diabetes prevalence, incidence and 
mortality on Ontario, Canada from 1995 to 2005. They were 
curious as to whether diabetes prevalence rates were in fact 
higher than those predicted during the period.
What they found was cause for concern. Age-adjusted and 
sex-adjusted diabetes prevalence increased by 69%, from 5.2% 
in a population of 7 908 562 in 1995 to 8.8% of 9 276 945 in 
2005. Prevalence increased by 27% from 6.9% in a population 
of 8 457 720 in 2000 to 8.8% of 9 276 945 in 2005. Although 
prevalence rates have remained higher in people aged 50 
years or older than in those aged 20 - 49 years, rates increased 
to a greater extent in the younger population. A 31% increase 
occurred in yearly incidence over 6 years, from 6.6 per 1 000 
in 1997 to 8.2 per 1 000 in 2003. The adjusted mortality rate in 
people with diabetes fell by 25% from 1995 to 2005.
They concluded that the prevalence of diabetes in Ontario, 
Canada increased substantially during the past 10 years, and 
by 2005 already exceeded the global rate that was predicted 
for 2030. This increase in prevalence is attributable to both 
rising incidence and declining mortality. Effective public-health 
interventions aimed at diabetes prevention are needed, as well 
as improved resources to manage the greater number of people 
living longer with the disease.
Lipscombe LL, Hux JE. Lancet 2007; 369:750-756.
Survival in chronic obstructive airways 
disease
Long-acting beta-agonists and inhaled corticosteroids have 
been used to treat chronic obstructive airways disease (COPD) 
for some time. However, their effect on survival of these 
patients is not known. Peter Calverley and colleagues carried 
out a randomised, double-blind trial comparing salmeterol 
at a dose of 50 µg plus fluticasone propionate at a dose of 
500 µg twice daily (combination regimen), administered with 
a single inhaler, with placebo, salmeterol alone, or fluticasone 
propionate alone for a period of 3 years. They looked at death 
from any cause, as well as the frequency of exacerbations, 
health status, and spirometric values. 
They found that of 6 112 patients in the efficacy population, 
875 died within 3 years after the start of the study treatment. 
All-cause mortality rates were 12.6% in the combination-
therapy group, 15.2% in the placebo group, 13.5% in the 
salmeterol group, and 16.0% in the fluticasone group. The use 
of combination therapy compared with the placebo group 
reduced the risk of death by 17.5%. However, the mortality 
rate for salmeterol alone or fluticasone propionate alone did 
not differ significantly from that for placebo. The combination 
regimen also reduced the annual rate of exacerbations from 1.13 
to 0.85 and improved health status and spirometric values. Use 
of fluticasone proprionate did increase the risk of pneumonia. 
However, the reduction in death from all causes among 
patients suffering from COPD using combination therapy 
was not statistically significant. The conclusion is that further, 
larger trials are still needed to examine the effect of these 
medications on mortality, although there definitely seems to be 
an improvement in quality of life.
Calverley PMA et al. NEJM 2007; 356:775-789.
Antioxidant supplements for primary 
and secondary prevention
The highly successful supplement industry is persuading 
people to take antioxidants in large quantities – promising a 
longer and healthier life, reduced disease and better ageing. 
The rationale is that there is evidence that people who eat 
large quantities of vegetables, fruit and certain types of fats 
have a reduced risk of many of the diseases of old age. The 
supplement industry promises the same effects from vitamin 
and mineral supplements – with antioxidant properties.
Goran Bjelakovic and colleagues searched electronic 
databases and bibliographies published by October 2005. Their 
aim was to assess the effect of antioxidant supplementation on 
primary and secondary prevention of disease. They included 
68 randomised trials with a total of 232 606 participants. All 
randomised trials involving adults comparing beta carotene, 
vitamin A, vitamin C (ascorbic acid), vitamin E, and selenium 
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either singly or combined versus placebo or versus no 
intervention were included in their analysis. 
They found that when all low- and high-bias risk trials of 
antioxidant supplements were pooled together there was no 
significant effect on mortality. Multivariate meta-regression 
analyses showed that low-bias risk trials and selenium were 
significantly associated with mortality. In 47 low-bias trials with 
180 938 participants, the antioxidant supplements significantly 
increased mortality. In low-bias risk trials, after exclusion of 
selenium trials, beta carotene, vitamin A, and vitamin E, singly 
or combined, significantly increased mortality. Vitamin C and 
selenium had no significant effect on mortality. 
So, the conclusion was that treatment with beta carotene, 
vitamin A, and vitamin E may actually increase mortality. Not 
something that will be widely publicised by the supplement 
industry.




By Anne Digby. Pp. 504. SFR 110. Peter Lang AG.2006.   
ISBN 3-03910-715-1.
This impressive work very aptly reflects that which its title 
conveys – diversity and division. It is not an example of the 
more conventional history of medicine by a historically minded 
(medical) doctor, but effectively a social history of health care 
by a professional historian.
The author is research professor in history at Oxford Brookes 
University. She has worked and taught in Britain, Japan and 
South Africa and has widely researched her subject in many 
libraries in these countries, where she has been in personal 
touch with numerous individuals and institutions.
The range of themes treated is notably broad: missionary 
medicine, 'Western' medicine, African indigenous medicine, 
medical training, nursing and nurses, patients, witchcraft, 
colonial framework, political background, and more. The text 
is amply supplied with detailed footnotes guiding the serious 
reader to appropriates sources. Not surprisingly a most striking 
feature of the work is its extensive 'Sources and bibliography'. 
This comprises subsections ranging from manuscripts, official 
papers, journals, articles and chapters, books, unpublished 
theses and papers, websites, oral testimony to sources of 
material culture – the whole section occupying no less than 39 
pages. A very adequate index completes the volume.The quality 
of all the illustrations (13) is rather disappointing. 
This soft-cover book is one of a series designated Studies in 
the History of Medicine edited by Charles Webster of All Souls 
College, Oxford. It constitutes a thorough and comprehensive 
contribution to South African social history and is a worthy 




By AT Ahuja, GE Antonio, KT Wong and HY Yuen. Pp v + 488. 
R570 incl. (P&P). Cambridge University Press. 2006.   
ISBN 0-521-68294-0
This book provides a concise overview of a well-selected 
and broad range of bread-and-butter conditions encountered 
in everyday radiology practice. Index cases are presented with 
pertinent clinical information and key images, together with a 
model report on the imaging. It is possible to tackle these cases 
in an undemanding test-yourself format, or to merely read 
through the text. At the end of each system-based section, a 
mini-review offers pearls on the topic raised by each case, often 
with the welcome addition of the spectrum of appearances of 
the same condition, and differential diagnoses.
The book is contemporary with a sensible mix of film and 
cross-sectional imaging, and prepares the reader for cases likely 
to be encountered on call. It is rather like using a film library 
with an experienced consultant at your side. It manages to 
cover a lot of ground by using this format, and is a welcome 
addition to the learning material directed at registrars starting 
out in clinical radiology, as well as interested medical students.
Steve Beningfield
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Dit is met innige leedwese dat ons verneem het van die afsterwe 
van Marthinus.
Nadat Marthinus sy MB ChB in 1945 aan die Universiteit van 
Kaapstad behaal het, het hy in verskeie plekke in Transvaal as 
algemene praktisyn gepraktiseer.
In 1952 ontvang hy die Fullbright Beurs om in Amerika 
in radiologie te spesialiseer.  Hy het die eer gehad om onder 
leiding van die bekende Professor Pendergrass in Philadelphia 
as radioloog te kwalifiseer.  Hy is waarskynlik die eerste Suid-
Afrikaner wat hierdie eer te beurt geval het.
As een van die min destyds gekwalifiseerde radioloë begin 
hy sy praktyk in Pretoria in Van Riebeeck Mediese Gebou.  
Hy was een van die min radioloë wat behalwe sy kennis van 
radio-diagnose, ook ‘n uitstekende radiograaf was en besondere 
kennis van die tegniese aspekte van X-straal apparaat gehad 
het.  Sy ontwerp van die sinograaf destyds is onder andere deur 
een van die X-straal vervaardigers oorgeneem en vir algemene 
gebruik vervaardig.
Na sy aftrede uit die grootste praktyk in Pretoria het 
hy vir ‘n hele aantal jare as senior konsultant by die HF 
Verwoerd-hospitaal gewerk. Met sy aftrede hier ontvang hy 
‘n pentekening waar hy by ‘n X-straal masjien staan met die 
onderskrif: ‘Wag eers ‘n bietjie ek wil net gou eers die masjien 
regmaak’.
Martinus het ook sy merk gemaak as bekwame bestuurder, 
nie net van sy eie praktyk nie, maar ook as voorsitter van die 
Sentrale Raad van die Radiologiese Vereniging van Suid-Afrika.
Marthinus was ‘n hoogs intelligente mens met hoë inbors, 
op wie jy kon staatmaak.  Sy liefde vir sy taal, sy volk, sy kerk 
en sy medemens was kenmerkend. Radiologie het een van sy 
grondleggers verloor, en hy sal deur elke geneesheer en veral 
die radioloë in die land gemis word. Ons kan van hom sê:  
‘Staan stil hier het ‘n man verby gegaan’.
Ons wil graag hiermee ons innige simpatie en medelye 
oordra aan sy vrou Kate en sy drie kinders Andries, Elsabe, 





On 30 November 2006 the 
Eye Unit at the Polokwane/
Mankweng Hospital 
Complex mourned the death 
of a respected friend and 
colleague, Dr Cope Khai, senior 
ophthalmologist at the Eye 
Unit. 
He was born on 19 February 
1953 in Burma, where his father 
was a chairman of the Chin 
State Council.  In December 
1977 he obtained his medical 
degree from the Institute of Medicine Mandalay, Burma.  After 
qualifying he worked as a private practitioner in Yangon, 
Burma, until 1982.  From April 1982, he worked in an ENT and 
eye hospital in Yangon, Burma.
On planning to relocate from Burma, he wrote the SA Medical 
and Dental Council examination and was appointed as Senior 
Medical Officer at the Jane Furse Hospital in the Lebowa 
homeland, where he was responsible for the eye services of 
the homeland.  In 2002 he joined the Polokwane/Mankweng 
Hospital Complex as registrar in ophthalmology and obtained 
the Fellowship in Ophthalmology in 2004.  At the time of his 
death he worked as senior ophthalmologist in the eye unit of 
the hospital complex.
We were grateful for the energy and enthusiasm which 
Dr Khai gave to his work.  We appreciate the support and 
strength he gave us in our challenging  tasks.
His passing brought eloquent tributes to his character and  
accomplishments, which were many indeed.  His endeavours 
left a deep imprint on eye care in the former homelands of 
Lebowa and the Limpopo province, serviced by the eye unit.  
His influence touched and inspired many lives.  His ability to 
inspire individuals to work with him and become members of 
the team was  phenomenal.  There was only one premise for 
both him and his colleagues, i.e. better quality care for patients.
During his 15 years of service in the Limpopo province, he 
performed more than 12 000 eye operations.  It was found 
fitting by the Ophthalmology Society of South Africa to award a 
humanitarian award to Dr Khai in 2006. 
He leaves behind his wife, a medical doctor, and three sons.
Dr IV de Jager and the medical colleagues of the Eye Unit
IN MEMORIAM
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